Cytokinetics, Incorporated · NASDAQ:CYTK

Harrington Robert Arthur received 151 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Jul 15, 2026 · Filed Jul 16, 2026

On Jul 15, 2026, Harrington Robert Arthur (Director) received 151 Cytokinetics, Incorporated shares as an award at US$82.62 for US$12,476, leaving 21,932 shares. Filed Jul 16, 2026 (Form 4).

Awarded
151 shares
Price
US$82.62
Value
US$12,476
Holding after
21,932 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Common StockAward151US$82.6221,932Direct

Source

View original at SEC

Related